Quironsalud Madrid
Chondrosarcoma treatment cost in Spain typically includes essential diagnostics like a PET-CT scan and primary surgical interventions such as bone resection, which runs from $20,000 to $35,000. For advanced cases, proton-beam therapy ranges from $25,600 to $65,100. Total expenses depend on the tumor stage and the need for reconstructive surgery, offering 40-70% savings compared to the US. Top treatment hubs include Barcelona, Madrid, and Pamplona.
Typical Chondrosarcoma Treatment Costs in Spain
Bookimed Expert Insight: Patients with complex sarcomas benefit most from multidisciplinary teams at JCI-accredited centers. Centro Médico Teknon is ideal for high-precision cases, as it features a specialized unit led by Dr. Joan Carles Galceran. For those requiring advanced radiotherapy, GenesisCare Clinics offer latest-generation external-beam options for over 15,000 patients annually. Quironsalud Madrid provides unique value through potential access to clinical trials for eligible cancer patients.
| Turkey | Austria | Spain | |
| Proton-beam therapy | from $70,000 | from $80,000 | from $25,559 |
| Proton therapy for prostate cancer | from $30,000 | from $80,000 | from $70,000 |
| Proton therapy for breast cancer | from $30,000 | from $55,000 | from $85,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Bone resection | from $8,000 | from $25,000 | from $20,000 |
Prof. Joan Carles Galceran leads the Genitourinary, CNS, Sarcoma, and Unknown Origin Tumors Unit at Vall d'Hebron University Hospital, specializing in complex sarcoma cases.
Specialist in Orthopedic Surgery and Traumatology at Clinica Universidad de Navarra.
The doctor is a pediatric oncologist with 37 years of experience, specializing in the treatment of blood disorders and performing procedures like bone marrow transplants and ablation therapy. The doctor is currently the Head of Paediatric Haemato-Oncology at Quironsalud Madrid University Hospital.
With a prolific academic record, the doctor has edited 14 books, contributed to 75 book chapters, and presented at over 200 conferences. The doctor is a member of several professional associations, including the Spanish Association of Paediatric Haematology and the Spanish Association of Paediatric Oncology.
The doctor treats a wide range of conditions, including leukemia, lymphoma, multiple myeloma, and various hematological and autoimmune disorders.
The doctor heads the Department of Urology and kidney transplantation at Teknon Medical Center in Barcelona, Spain, with over 30 years of experience. Specializing in uro-oncology and transplantology, the doctor has overseen more than 500 successful operations, focusing on pathologies of the urogenital system using minimally invasive methods, including laparoscopic and robotic-assisted surgeries.
The doctor is particularly noted for expertise in prostate cancer treatment and utilizes the Da Vinci robotic system for innovative surgical procedures. Additionally, the doctor treats congenital pathologies in children such as cryptorchism and is a member of the American Urological Confederation, Urological Association of Spain, and European Urological Society.
Standard treatment for chondrosarcoma in Spain centers on complete surgical resection with wide negative margins. Spanish oncology teams follow strict protocols established by the Spanish Group for Research on Sarcoma. Surgery remains primary because these tumors often resist conventional chemotherapy and radiation therapies.
Bookimed Expert Insight: Spanish oncology centers like Proton Therapy Centre Quironsalud and Centro Médico Teknon provide a specific advantage for complex axial skeleton tumors. While standard surgery is common globally, Spain has integrated the Proteus ONE proton system specifically for unresectable chondrosarcomas. Data shows these centers attract international patients by combining JCI-accredited surgical precision with highly specialized radiation that protects nearby vital organs. For patients with skull-base involvement, these bundled diagnostic and therapy packages offer a streamlined path to treatments not available in many other European regions.
Spain offers advanced proton beam therapy for chondrosarcoma at specialized oncology centers in Madrid. Facilities like Proton Therapy Centre Quironsalud utilize the Proteus ONE system. This technology delivers high-precision radiation to bone tumors while protecting critical structures like the brainstem and spinal cord.
Bookimed Expert Insight: While Spain has several top-tier oncology centers, specialized proton therapy for rare sarcomas is concentrated in Madrid. A notable differentiator is the clinical experience of the specialists. For example, Dr. Carme Ares at Quironsalud trained at Massachusetts General Hospital in Boston, a global pioneer in proton technology. This specific expertise in rare tumors is often more critical than the machine itself for successful outcomes.
Patient Consensus: Patients note that while the technology exists, access depends on a multidisciplinary tumor board review. Many emphasize that verifying the center's regular experience with rare bone sarcomas is vital for peace of mind.
Spain hosts several centers of excellence for chondrosarcoma recognized by the Ministry of Health (CSUR) and international bodies like JCI. Key institutions include Vall d Hebron University Hospital, Hospital Universitario La Paz, and private leaders like Clinica Universidad de Navarra and Teknon Medical Center.
Bookimed Expert Insight: Data suggests a geographical divide in specialized treatments. Madrid centers like Quironsalud Madrid focus heavily on high-precision radiotherapy. In contrast, Barcelona facilities like Centro Medico Teknon and Hospital Quiron Barcelona lead in high-volume surgical oncology. Patients requiring complex limb-sparing surgery should look for centers performing over 23,000 annual operations to ensure deep surgical expertise.
Patient Consensus: Patients emphasize that a specialized sarcoma tumor board review is essential. They note that biopsy planning must be handled by the specific orthopedic oncology team performing the final surgery to ensure the best outcome.
International patients can enroll in clinical trials for metastatic chondrosarcoma in Spain. Specialized networks like the Spanish Sarcoma Research Group (GEIS) manage these opportunities. Enrollment depends on trial protocols, biomarker profiles, and pathology reports. Access is determined on a case-by-case basis at JCI-accredited centers.
Bookimed Expert Insight: Spain ranks 7th globally in our network for complex oncology requests. While Quironsalud Madrid offers free treatment through trials, these spots are highly competitive. Patients should prioritize clinics with dedicated research units like Teknon or HM Madrid. These institutions handle over 23,000 operations yearly and have deeper trial infrastructure.
Patient Consensus: Patients note that being eligible to apply differs from being accepted for treatment. Having all pathology and molecular tests translated into Spanish significantly speeds up the review process.